PRICE T ROWE ASSOCIATES INC /MD/ - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$267
-18.8%
39,892
+1.9%
0.00%
Q2 2023$329
-33.3%
39,150
-21.0%
0.00%
Q1 2023$493
+42.9%
49,5870.0%0.00%
Q4 2022$345
-99.8%
49,587
+44.2%
0.00%
Q3 2022$184,000
+1.7%
34,387
-24.1%
0.00%
Q2 2022$181,000
-12.1%
45,310
-2.3%
0.00%
Q1 2022$206,000
+39.2%
46,364
+25.1%
0.00%
Q4 2021$148,000
+51.0%
37,064
+232.0%
0.00%
Q3 2021$98,000
-23.4%
11,164
-0.9%
0.00%
Q2 2021$128,00011,2640.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders